Table I.
Sociodemographic features of the sample and characteristics of chronic spontaneous urticaria (CSU) (n = 75)
Characteristics | |
---|---|
Socio-demographic features | |
Age, years, mean (SD) | 46.48 (11.25) |
Sex, % (n) | |
Male | 29.3 (22/75) |
Female | 70.7 (53/75) |
Marital status, % (n) | |
In a couple | 77.3 (58/75) |
Single | 22.7 (17/75) |
Occupation, % (n) | |
Employed | 78.7 (59/75) |
Unemployed | 21.3 (16/75) |
Educational level, % (n) | |
Basic education | 8 (6/75) |
Secondary education | 13.3 (10/75) |
Professional education | 28 (21/75) |
University education | 50.7 (38/75) |
Disease characteristics | |
Disease duration, years, mean (SD) | 10.73 (10.69) |
Urticaria Control Test score, mean (SD) | 18.64 (6.90) |
Disease duration, % (n) | |
<10 years | 60 (45/75) |
>10 years | 40 (30/75) |
Current treatment for CSU, % (n) | |
Antihistamines | 41.3 (31/75) |
Antihistamines + corticosteroids | 6.7 (5/75) |
Corticosteroids | 2.7 (2/75) |
Omalizumab | 38.7 (29/75) |
No medical treatment | 10.6 (8/75) |
Quality of life indicators | |
DLQI, mean (SD) | 8.12 (7.15) |
DS14 (% of positive test), % (n) | 28 (21/75) |
HADS Depression (% of positive test), % (n) | 41.33 (31/75) |
FSFI (% of female sexual dysfunction), % (n) | 54.54 (30/55) |
Overall CUQoL, mean (SD) | 28.63 (21.73) |
PSQI, mean (SD) | 9.53 (4.68) |
HADS Anxiety (% of positive test), % (n) | 46.67 (35/75) |
IIEF (% of male sexual dysfunction), % (n) | 63.63 (14/22) |
CUQoL: Chronic Urticaria Quality of Life questionnaire; CSU: chronic spontaneous urticaria; DLQI: Dermatology Quality of Life Index; DS14: Type D-14 scale; FSFI Female Sexual Function Index; HADS: Hospital Anxiety and Depression Scale; IIEF: International Index of Erectile Function; PSQI: Pittsburg Sleep Quality Index; SD: standard deviation.